DETOPS
Age-related diseases (Neurodegenerative, Cardiovascular, Metabolic)
Pre-clinicalActive
Key Facts
Indication
Age-related diseases (Neurodegenerative, Cardiovascular, Metabolic)
Phase
Pre-clinical
Status
Active
Company
About AntiRadical Therapeutics
AntiRadical Therapeutics LLC is a preclinical-stage biotech focused on developing novel anti-aging drugs based on stable nitroxide free radicals. Its lead candidate, DETOPS, is positioned as a next-generation therapy targeting oxidative stress, cellular signaling, and vascular dynamics to address age-related conditions like neurodegenerative and cardiovascular diseases. The company is private, pre-revenue, and appears to be in the early stages of validating its platform and advancing its lead program through preclinical development.
View full company profile